| Literature DB >> 17275817 |
Eun Hee Han1, Yong Pil Hwang, Tae Cheon Jeong, Sang Seop Lee, Jae-Gook Shin, Hye Gwang Jeong.
Abstract
Typically, chemopreventive agents either inhibit the cytochrome P450s (CYPs) that are essential for the metabolism of carcinogens or induce phase II detoxifying enzymes. This study examined the chemopreventive effect of eugenol on 7,12-dimethylbenz[a]anthracene (DMBA)-induced DNA damage in MCF-7 cells. Eugenol inhibited the formation of the DMBA-DNA adduct in a dose dependent manner. CYP1A1 and CYP1B1 activity, which catalyze the biotransformation of DMBA, were strongly inhibited by eugenol. Eugenol also suppressed the CYP1A induction by DMBA through decreased aryl hydrocarbon receptor activation and subsequent DNA binding. Furthermore, eugenol increased the expression and activity of NAD(P)H:quinone oxidoreductase (QR), a major detoxifying enzyme for DMBA, through NF-E2 related factor2 binding to antioxidant response element in QR gene. Therefore, eugenol has a potent protective effect against DMBA-induced genotoxicity, presumably through the suppression of the DMBA activation and the induction of its detoxification. These results suggest that eugenol has potential as a chemopreventive.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17275817 DOI: 10.1016/j.febslet.2007.01.044
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124